Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3091% above fair value
$86.48+0.42 (+0.49%)
Close on Nov 18, 2026Market cap $14.72BP/E 97.2Yield –
Solventum gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Solventum's gross profit for the twelve months ending Sep 30, 2026 was $4.47B, down 1.6% year over year. For fiscal 2025 it was $4.45B, down 3.1% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.45B | -3.1% |
| FY2024 | Dec 31, 2024 | $4.59B | -2.1% |
| FY2023 | Dec 31, 2023 | $4.69B | -0.0% |
| FY2022 | Dec 31, 2022 | $4.70B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.06B | -6.4% |
| Q2 FY2026 | Jun 30, 2026 | $1.29B | +9.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.10B | -1.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.03B | -8.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.14B | -2.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.18B | +3.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.11B | -4.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.12B | -3.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.17B | -3.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.14B | -4.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.17B | +3.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.16B | – |
| Q3 FY2023 | Sep 30, 2023 | $1.21B | – |
| Q2 FY2023 | Jun 30, 2023 | $1.19B | – |
| Q1 FY2023 | Mar 31, 2023 | $1.14B | – |
See a number that looks wrong?